Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase IIIb study

References

• AgustiAHednerJMarinJMBarbéFCazzolaMRennardSNighttime symptoms: a forgotten dimension of COPDEur Respir Rev20112012118319421881146
   PubMedGoogle Scholar
• RocheNChavannesNHMiravitllesMCOPD symptoms in the morning: impact, evaluation and managementRespir Res20131411224143997
   PubMed Web of Science ®Google Scholar
• MiravitllesMWorthHSoler CatalunaJJObservational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS studyRespir Res20141512225331383
   PubMed Web of Science ®Google Scholar
• Ehteshami-AfsharSFitzGeraldJMDoyle-WatersMMSadatsafaviMThe global economic burden of asthma and chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis201620112326688525
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [updated 2017] Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/Accessed November 17, 2016
   Google Scholar
• BeierJKirstenAMMrózREfficacy and safety of aclidinium bromide compared with placebo and tiotropium in patients with moderate-to-severe chronic obstructive pulmonary disease: results from a 6-week, randomized, controlled Phase IIIb studyCOPD201310451152223819698
   PubMedGoogle Scholar
• FuhrRMagnussenHSaremKEfficacy of aclidinium bromide 400 μg twice daily compared with placebo and tiotropium in patients with moderate to severe COPDChest2012141374575221903737
   PubMed Web of Science ®Google Scholar
• MarthKSchullerEPohlWImprovements in patient-reported outcomes: a prospective, non-interventional study with aclidinium bromide for treatment of COPDRespir Med2015109561662425796962
   PubMed Web of Science ®Google Scholar
• BeierJKirstenA-MMrozREfficacy of aclidinium bromide compared with tiotropium and placebo in patients with moderate to severe COPD: a phase IIIb studyThorax201267A26A27
   Web of Science ®Google Scholar
• FuhrRMagnussenHRibera LloveraAEfficacy and safety of twice-daily aclidinium bromide compared with tiotropium and placebo in patients with moderate to severe COPDEur Respir J201036Suppl 54219s
   Google Scholar
• JonesPWLeidyNKHareendranALamarcaRChuecosFGarcia GilEThe effect of aclidinium bromide on daily respiratory symptoms of COPD, measured using the Evaluating Respiratory Symptoms in COPD (E-RS: COPD) diary: pooled analysis of two 6-month Phase III studiesRespir Res20161716127215749
   PubMed Web of Science ®Google Scholar
• LeidyNKMurrayLTJonesPSethiSPerformance of the EXAcerbations of chronic pulmonary disease tool patient-reported outcome measure in three clinical trials of chronic obstructive pulmonary diseaseAnn Am Thorac Soc20141131632524432712
   PubMedGoogle Scholar
• LeidyNKSextonCCJonesPWMeasuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diaryThorax201469544344924595666
   PubMed Web of Science ®Google Scholar
• LeidyNKMurrayLTMonzBUMeasuring respiratory symptoms of COPD: performance of the EXACT-Respiratory Symptoms Tool (E-RS) in three clinical trialsRespir Res201415112425287629
   PubMed Web of Science ®Google Scholar
• MocarskiMZaiserETrundellDMakeBJHareendranAEvaluation of the psychometric properties of the nighttime symptoms of COPD instrumentInt J Chron Obstruct Pulmon Dis20151047548725834415
   PubMed Web of Science ®Google Scholar
• HareendranAZaiserEMakeBGarcia-GilEThe development and psychometric validation of the early morning symptoms of COPD instrument (EMSCI)Thorax201671Suppl 3A204 P218 (abstract)
   Web of Science ®Google Scholar
• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory SocietyAnn Intern Med2011155317919121810710
   PubMed Web of Science ®Google Scholar
• CalverleyPMLeeATowseLvan NoordJWitekTJKelsenSEffect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary diseaseThorax2003581085586014514937
   PubMed Web of Science ®Google Scholar
• MartinRJBartelsonBLSmithPEffect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPDChest199911551338134510334150
   PubMed Web of Science ®Google Scholar
• McNicholasWTCalverleyPMLeeAEdwardsJCLong-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPDEur Respir J200423682583115218993
   PubMed Web of Science ®Google Scholar
• MulloyEMcNicholasWTTheophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary diseaseAm Rev Respir Dis19931484 Pt 1103010368214921
   PubMed Web of Science ®Google Scholar
• RyanSDohertyLSRockCNolanGMMcNicholasWTEffects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary diseaseRespiration201079647548119684384
   PubMed Web of Science ®Google Scholar
• LeidyNKKimelMAjagbeLKimKHamiltonABeckerKDesigning trials of behavioral interventions to increase physical activity in patients with COPD: insights from the chronic disease literatureRespir Med2014108347248124315467
   PubMed Web of Science ®Google Scholar